Vasa Denticity Ltd

- As of now, there are no major capex plans decided for FY27, implying no immediate large funding requirement. - The company did not mention any ongoing or planned new fundraising through debt or equity in the transcript. - They emphasize focusing on cash flow discipline, profitability, and gradual investments rather than heavy capital burn. - Any changes or new fundraising activities will be communicated appropriately in the future. - The management is committed to long-term value creation without depending on aggressive capital raising in the short term.

- No major capex plans have been decided for FY27 as of now. - If any changes occur regarding capex, the company will communicate them appropriately. - Significant fixed-cost investments have already been made in warehousing during H1, enabling operating leverage going forward. - Tech investments have largely been completed with a revamped app and website; future upgrades will be continuous but not capital-intensive. - Investment focus remains on building service centres, with plans for own service centres in all Tier I cities within two years. - The company continues to assess strategic acquisitions (e.g., IDS Denmed) for long-term value but pursues only those adding genuine strategic value for dentists.

- Targeting ₹500–600 crore revenue by FY27, broadly on track with directional targets. - Aspirational revenue range of ₹800–1,200 crore by FY29, though dependent on execution factors. - Growth levers include increasing active customers (e.g., from 60,000 to 100,000 monthly) and increasing wallet share per customer (e.g., from 15% to 40%). - Emphasis on deepening market penetration and wallet share rather than just short-term growth. - Smileworks lab is on a path to break-even with potential to exceed ₹50 crore revenue in the long term, though timeline is uncertain. - Delivery timeline improvements (targeting same-day in Tier I cities and average below 48 hours nationwide) aimed to support revenue growth. - Investments in inventory and warehouses intended to balance faster delivery and margin discipline while enabling scale. - Long-term vision includes building the dominant dental ecosystem in India with 5x to 10x scalability from current levels.

- The company targets revenue of ₹500–600 crore by FY27 and ₹800–1,200 crore by FY29, viewing these as directional aspirations rather than firm guidance. - Growth is expected to be driven mainly by ARPU expansion and increased wallet share from existing and new customers. - Operating leverage is anticipated as tech and warehousing investments mature, with variable incremental costs lower than proportional order volume growth. - EBITDA margins currently compressed due to investments but expected to improve toward mid-teens over time as stability and efficiencies increase. - Focus on building a strong, defensible business without heavy cash burn aimed at sustainable, long-term profitability. - One-hour quarterly earnings calls initiated to provide continual updates and maintain transparency on growth and profitability progress.

- The transcript does not explicitly mention the current or expected order book or pending orders. - Focus is on improving delivery timelines, expanding product coverage, and strengthening service quality to convert more demand into revenue. - Current delivery time averages around 4 days; the company aspires to reduce this below 48 hours across Tier I cities. - The firm prioritizes having enough inventory to avoid stockouts, even if it leads to temporarily higher inventory days (currently expected to stabilize at 120–150 days). - Investments in warehouses and inventory imply readiness to handle growing order volumes. - The company is improving operational efficiencies and tech capacity to potentially handle 3x the current order volume. - No detailed numeric data on order backlog or pending orders is provided publicly in this transcript.